EUVIMEDEUVIMED entdecken
Open Access

MMUT Clinical Variants Define a Goldilocks Zone for B12-Based Radical Chemistry

Markus Ruetz iD, Benjamin Krukonis, Romila Mascarenhas iD, Ruma Banerjee iD

Biochemistry · 17.11.2026 · 65 (22) · 3693-3701

DOI: 10.1021/acs.biochem.6c00258 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemistry, online erschienen am 12.08.2026. Verfasst von Markus Ruetz und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Chemistry, University of Michigan, Ann Arbor, Michigan48109, United States. Hauptthemen laut MEDLINE: Vitamin B 12, Cobamides, Mutation, Missense, Methylmalonyl-CoA Mutase. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NIGMS NIH HHS, National Institute of Diabetes and Digestive and Kidney Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

MMUT is one of only two enzymes in the human proteome that depend on the B12 cofactor for activity. It catalyzes the isomerization of methylmalonyl-CoA to succinyl-CoA using 5′-deoxyadenosylcobalamin (AdoCbl) as a radical generator. Clinical mutations in MMUT are inherited in an autosomal recessive manner and are classified as B12-responsive mut– and B12 unresponsive mut0 subgroups. In this study, we report that missense mutations located at the same residue, i.e., Ala-137, are associated with distinct biochemical penalties. While the A137G mutation disables cofactor loading from the MMAB chaperone, it shows an ∼700-fold weaker affinity for binding AdoCbl from solution and exhibits an ∼700-fold lower activity than the wild-type enzyme. In contrast, the A137V variant binds AdoCbl tightly, can be partially loaded with cofactor from MMAB from solution, but exhibits ∼5000-fold lower activity, consistent with its mut0 classification. Despite the overall similarity in the crystal structure with wild-type MMUT, a close-up of the A137V active site reveals profound differences in the 5′-deoxyadenosyl moiety, which is held in a previously unseen pose. Structural analyses predict that while Gly-137 is too small to correctly position Tyr-110, critical for transition state stabilization, Val-137 is too large to even accommodate it, exemplifying the catalysis-permissive Goldilocks zone at this site. Our study predicts that the A137G variant might belong to the mut– subgroup and exhibit therapeutic responsiveness to a high dose of B12.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vitamin B 12CobamidesMutation, MissenseMethylmalonyl-CoA MutaseHumansModels, Molecular

Substanzen

Vitamin B 12CobamidescobamamideMethylmalonyl-CoA Mutase

Autor:innen und Institutionen

  • Department of Biological Chemistry, University of Michigan, Ann Arbor, Michigan48109, United States.
  • Department of Chemistry and Biochemistry, University of Oregon, Eugene, Oregon97403, United States.
  • Institute of Molecular Biology, University of Oregon, Eugene, Oregon97403, United States.

ORCID-Profile: Markus Ruetz, Romila Mascarenhas, Ruma Banerjee

Förderung

  • NIDDK NIH HHS
  • NIGMS NIH HHS
  • National Institute of Diabetes and Digestive and Kidney Diseases
  • National Institute of General Medical Sciences

Zitieren

APA

Ruetz, M., Krukonis, B., Mascarenhas, R., & Banerjee, R. (2026). MMUT Clinical Variants Define a Goldilocks Zone for B12-Based Radical Chemistry. Biochemistry, 65(22), 3693-3701. https://doi.org/10.1021/acs.biochem.6c00258

Vancouver

Ruetz M, Krukonis B, Mascarenhas R, Banerjee R. MMUT Clinical Variants Define a Goldilocks Zone for B12-Based Radical Chemistry. Biochemistry. 2026;65(22):3693-3701. doi:10.1021/acs.biochem.6c00258

BibTeX
@article{Ruetz2026,
  author = {Ruetz, Markus and Krukonis, Benjamin and Mascarenhas, Romila and Banerjee, Ruma},
  title = {MMUT Clinical Variants Define a Goldilocks Zone for B12-Based Radical Chemistry},
  journal = {Biochemistry},
  year = {2026},
  volume = {65},
  number = {22},
  pages = {3693--3701},
  doi = {10.1021/acs.biochem.6c00258}
}
Kostenlos starten →